Biolife Solutions (BLFS) Depreciation & Amortization (CF) (2010 - 2026)

Biolife Solutions (BLFS) has reported Depreciation & Amortization (CF) for 17 consecutive years, with $374000.0 the latest figure, recorded in Q1 2026.

• In Q1 2026, Depreciation & Amortization (CF) fell 45.16% year-over-year to $374000.0; the TTM figure through Mar 2026 stood at $1.9 million (down 56.57% YoY), while the FY2025 annual figure was $2.3 million, down 56.34% from the prior year.
• Depreciation & Amortization (CF) improved to $374000.0 in Q1 2026 per BLFS's latest filing, from $261000.0 in the prior quarter.
• Across five years, Depreciation & Amortization (CF) topped out at $2.0 million in Q2 2023 and bottomed at $261000.0 in Q4 2025.
• Historically, Depreciation & Amortization (CF) has averaged $1.3 million across 5 years, with a median of $1.5 million in 2024.
• Annual changes were most pronounced in 2022 — Depreciation & Amortization (CF) surged 112.74% — and 2025, when it tumbled 72.15%.
• Biolife Solutions' Depreciation & Amortization (CF) stood at $1.7 million in 2022, then dropped by 14.6% to $1.5 million in 2023, then sank by 36.17% to $937000.0 in 2024, then sank by 72.15% to $261000.0 in 2025, then jumped by 43.3% to $374000.0 in 2026.
• Business Quant data shows BLFS's Depreciation & Amortization (CF) at $374000.0 in Q1 2026, $261000.0 in Q4 2025, and $636000.0 in Q3 2025.